 | • レポートコード：MRC2312MG14596 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、72ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の生分解性埋め込み型薬物送達システム市場規模と予測を収録しています。・世界の生分解性埋め込み型薬物送達システム市場：売上、2018年-2023年、2024年-2029年 ・世界の生分解性埋め込み型薬物送達システム市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の生分解性埋め込み型薬物送達システム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「皮下インプラント型」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 生分解性埋め込み型薬物送達システムのグローバル主要企業は、Abbive、 TerSera Therapeutics、 Azurity、 Simcere、 Intersect ENT、 Clinuvel、 Innocoll Biotherapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、生分解性埋め込み型薬物送達システムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の生分解性埋め込み型薬物送達システム市場：タイプ別、2018年-2023年、2024年-2029年 世界の生分解性埋め込み型薬物送達システム市場：タイプ別市場シェア、2022年 ・皮下インプラント型、注入インプラント型、その他 世界の生分解性埋め込み型薬物送達システム市場：用途別、2018年-2023年、2024年-2029年 世界の生分解性埋め込み型薬物送達システム市場：用途別市場シェア、2022年 ・腫瘍、眼科、その他 世界の生分解性埋め込み型薬物送達システム市場：地域・国別、2018年-2023年、2024年-2029年 世界の生分解性埋め込み型薬物送達システム市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における生分解性埋め込み型薬物送達システムのグローバル売上、2018年-2023年 ・主要企業における生分解性埋め込み型薬物送達システムのグローバル売上シェア、2022年 ・主要企業における生分解性埋め込み型薬物送達システムのグローバル販売量、2018年-2023年 ・主要企業における生分解性埋め込み型薬物送達システムのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Abbive、 TerSera Therapeutics、 Azurity、 Simcere、 Intersect ENT、 Clinuvel、 Innocoll Biotherapeutics ************************************************************* ・調査・分析レポートの概要 生分解性埋め込み型薬物送達システム市場の定義 市場セグメント 世界の生分解性埋め込み型薬物送達システム市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の生分解性埋め込み型薬物送達システム市場規模 世界の生分解性埋め込み型薬物送達システム市場規模：2022年 VS 2029年 世界の生分解性埋め込み型薬物送達システム市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの生分解性埋め込み型薬物送達システムの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の生分解性埋め込み型薬物送達システム製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：皮下インプラント型、注入インプラント型、その他 生分解性埋め込み型薬物送達システムのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：腫瘍、眼科、その他 生分解性埋め込み型薬物送達システムの用途別グローバル売上・予測 ・地域別市場分析 地域別生分解性埋め込み型薬物送達システム市場規模 2022年と2029年 地域別生分解性埋め込み型薬物送達システム売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Abbive、 TerSera Therapeutics、 Azurity、 Simcere、 Intersect ENT、 Clinuvel、 Innocoll Biotherapeutics ... |
This research report provides a comprehensive analysis of the Biodegradable Implantable Drug Delivery System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biodegradable Implantable Drug Delivery System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biodegradable Implantable Drug Delivery System, challenges faced by the industry, and potential opportunities for market players.
The global Biodegradable Implantable Drug Delivery System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biodegradable Implantable Drug Delivery System market presents opportunities for various stakeholders, including Tumor, Ophthalmology. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biodegradable Implantable Drug Delivery System market. Additionally, the growing consumer demand present avenues for market expansion.
The global Biodegradable Implantable Drug Delivery System market was valued at US$ 1088.4 million in 2022 and is projected to reach US$ 1661.8 million by 2029, at a CAGR of 6.3% during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The research report on the Biodegradable Implantable Drug Delivery System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biodegradable Implantable Drug Delivery System market.
Market Overview: The report provides a comprehensive overview of the Biodegradable Implantable Drug Delivery System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Subcutaneous Implant Type, Injection Implant Type), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biodegradable Implantable Drug Delivery System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biodegradable Implantable Drug Delivery System market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biodegradable Implantable Drug Delivery System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biodegradable Implantable Drug Delivery System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biodegradable Implantable Drug Delivery System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biodegradable Implantable Drug Delivery System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biodegradable Implantable Drug Delivery System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biodegradable Implantable Drug Delivery System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biodegradable Implantable Drug Delivery System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Subcutaneous Implant Type
Injection Implant Type
Other
Market segment by Application
Tumor
Ophthalmology
Other
Global Biodegradable Implantable Drug Delivery System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Abbive
TerSera Therapeutics
Azurity
Simcere
Intersect ENT
Clinuvel
Innocoll Biotherapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biodegradable Implantable Drug Delivery System, market overview.
Chapter 2: Global Biodegradable Implantable Drug Delivery System market size in revenue and volume.
Chapter 3: Detailed analysis of Biodegradable Implantable Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biodegradable Implantable Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biodegradable Implantable Drug Delivery System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Biodegradable Implantable Drug Delivery System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biodegradable Implantable Drug Delivery System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biodegradable Implantable Drug Delivery System Overall Market Size
2.1 Global Biodegradable Implantable Drug Delivery System Market Size: 2022 VS 2029
2.2 Global Biodegradable Implantable Drug Delivery System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biodegradable Implantable Drug Delivery System Sales: 2018-2029
3 Company Landscape
3.1 Top Biodegradable Implantable Drug Delivery System Players in Global Market
3.2 Top Global Biodegradable Implantable Drug Delivery System Companies Ranked by Revenue
3.3 Global Biodegradable Implantable Drug Delivery System Revenue by Companies
3.4 Global Biodegradable Implantable Drug Delivery System Sales by Companies
3.5 Global Biodegradable Implantable Drug Delivery System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biodegradable Implantable Drug Delivery System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biodegradable Implantable Drug Delivery System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biodegradable Implantable Drug Delivery System Players in Global Market
3.8.1 List of Global Tier 1 Biodegradable Implantable Drug Delivery System Companies
3.8.2 List of Global Tier 2 and Tier 3 Biodegradable Implantable Drug Delivery System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Biodegradable Implantable Drug Delivery System Market Size Markets, 2022 & 2029
4.1.2 Subcutaneous Implant Type
4.1.3 Injection Implant Type
4.1.4 Other
4.2 By Type – Global Biodegradable Implantable Drug Delivery System Revenue & Forecasts
4.2.1 By Type – Global Biodegradable Implantable Drug Delivery System Revenue, 2018-2023
4.2.2 By Type – Global Biodegradable Implantable Drug Delivery System Revenue, 2024-2029
4.2.3 By Type – Global Biodegradable Implantable Drug Delivery System Revenue Market Share, 2018-2029
4.3 By Type – Global Biodegradable Implantable Drug Delivery System Sales & Forecasts
4.3.1 By Type – Global Biodegradable Implantable Drug Delivery System Sales, 2018-2023
4.3.2 By Type – Global Biodegradable Implantable Drug Delivery System Sales, 2024-2029
4.3.3 By Type – Global Biodegradable Implantable Drug Delivery System Sales Market Share, 2018-2029
4.4 By Type – Global Biodegradable Implantable Drug Delivery System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biodegradable Implantable Drug Delivery System Market Size, 2022 & 2029
5.1.2 Tumor
5.1.3 Ophthalmology
5.1.4 Other
5.2 By Application – Global Biodegradable Implantable Drug Delivery System Revenue & Forecasts
5.2.1 By Application – Global Biodegradable Implantable Drug Delivery System Revenue, 2018-2023
5.2.2 By Application – Global Biodegradable Implantable Drug Delivery System Revenue, 2024-2029
5.2.3 By Application – Global Biodegradable Implantable Drug Delivery System Revenue Market Share, 2018-2029
5.3 By Application – Global Biodegradable Implantable Drug Delivery System Sales & Forecasts
5.3.1 By Application – Global Biodegradable Implantable Drug Delivery System Sales, 2018-2023
5.3.2 By Application – Global Biodegradable Implantable Drug Delivery System Sales, 2024-2029
5.3.3 By Application – Global Biodegradable Implantable Drug Delivery System Sales Market Share, 2018-2029
5.4 By Application – Global Biodegradable Implantable Drug Delivery System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Biodegradable Implantable Drug Delivery System Market Size, 2022 & 2029
6.2 By Region – Global Biodegradable Implantable Drug Delivery System Revenue & Forecasts
6.2.1 By Region – Global Biodegradable Implantable Drug Delivery System Revenue, 2018-2023
6.2.2 By Region – Global Biodegradable Implantable Drug Delivery System Revenue, 2024-2029
6.2.3 By Region – Global Biodegradable Implantable Drug Delivery System Revenue Market Share, 2018-2029
6.3 By Region – Global Biodegradable Implantable Drug Delivery System Sales & Forecasts
6.3.1 By Region – Global Biodegradable Implantable Drug Delivery System Sales, 2018-2023
6.3.2 By Region – Global Biodegradable Implantable Drug Delivery System Sales, 2024-2029
6.3.3 By Region – Global Biodegradable Implantable Drug Delivery System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Biodegradable Implantable Drug Delivery System Revenue, 2018-2029
6.4.2 By Country – North America Biodegradable Implantable Drug Delivery System Sales, 2018-2029
6.4.3 US Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.4.4 Canada Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.4.5 Mexico Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Biodegradable Implantable Drug Delivery System Revenue, 2018-2029
6.5.2 By Country – Europe Biodegradable Implantable Drug Delivery System Sales, 2018-2029
6.5.3 Germany Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.5.4 France Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.5.5 U.K. Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.5.6 Italy Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.5.7 Russia Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.5.8 Nordic Countries Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.5.9 Benelux Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Biodegradable Implantable Drug Delivery System Revenue, 2018-2029
6.6.2 By Region – Asia Biodegradable Implantable Drug Delivery System Sales, 2018-2029
6.6.3 China Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.6.4 Japan Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.6.5 South Korea Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.6.6 Southeast Asia Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.6.7 India Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Biodegradable Implantable Drug Delivery System Revenue, 2018-2029
6.7.2 By Country – South America Biodegradable Implantable Drug Delivery System Sales, 2018-2029
6.7.3 Brazil Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.7.4 Argentina Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Biodegradable Implantable Drug Delivery System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Biodegradable Implantable Drug Delivery System Sales, 2018-2029
6.8.3 Turkey Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.8.4 Israel Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.8.5 Saudi Arabia Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
6.8.6 UAE Biodegradable Implantable Drug Delivery System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbive
7.1.1 Abbive Company Summary
7.1.2 Abbive Business Overview
7.1.3 Abbive Biodegradable Implantable Drug Delivery System Major Product Offerings
7.1.4 Abbive Biodegradable Implantable Drug Delivery System Sales and Revenue in Global (2018-2023)
7.1.5 Abbive Key News & Latest Developments
7.2 TerSera Therapeutics
7.2.1 TerSera Therapeutics Company Summary
7.2.2 TerSera Therapeutics Business Overview
7.2.3 TerSera Therapeutics Biodegradable Implantable Drug Delivery System Major Product Offerings
7.2.4 TerSera Therapeutics Biodegradable Implantable Drug Delivery System Sales and Revenue in Global (2018-2023)
7.2.5 TerSera Therapeutics Key News & Latest Developments
7.3 Azurity
7.3.1 Azurity Company Summary
7.3.2 Azurity Business Overview
7.3.3 Azurity Biodegradable Implantable Drug Delivery System Major Product Offerings
7.3.4 Azurity Biodegradable Implantable Drug Delivery System Sales and Revenue in Global (2018-2023)
7.3.5 Azurity Key News & Latest Developments
7.4 Simcere
7.4.1 Simcere Company Summary
7.4.2 Simcere Business Overview
7.4.3 Simcere Biodegradable Implantable Drug Delivery System Major Product Offerings
7.4.4 Simcere Biodegradable Implantable Drug Delivery System Sales and Revenue in Global (2018-2023)
7.4.5 Simcere Key News & Latest Developments
7.5 Intersect ENT
7.5.1 Intersect ENT Company Summary
7.5.2 Intersect ENT Business Overview
7.5.3 Intersect ENT Biodegradable Implantable Drug Delivery System Major Product Offerings
7.5.4 Intersect ENT Biodegradable Implantable Drug Delivery System Sales and Revenue in Global (2018-2023)
7.5.5 Intersect ENT Key News & Latest Developments
7.6 Clinuvel
7.6.1 Clinuvel Company Summary
7.6.2 Clinuvel Business Overview
7.6.3 Clinuvel Biodegradable Implantable Drug Delivery System Major Product Offerings
7.6.4 Clinuvel Biodegradable Implantable Drug Delivery System Sales and Revenue in Global (2018-2023)
7.6.5 Clinuvel Key News & Latest Developments
7.7 Innocoll Biotherapeutics
7.7.1 Innocoll Biotherapeutics Company Summary
7.7.2 Innocoll Biotherapeutics Business Overview
7.7.3 Innocoll Biotherapeutics Biodegradable Implantable Drug Delivery System Major Product Offerings
7.7.4 Innocoll Biotherapeutics Biodegradable Implantable Drug Delivery System Sales and Revenue in Global (2018-2023)
7.7.5 Innocoll Biotherapeutics Key News & Latest Developments
8 Global Biodegradable Implantable Drug Delivery System Production Capacity, Analysis
8.1 Global Biodegradable Implantable Drug Delivery System Production Capacity, 2018-2029
8.2 Biodegradable Implantable Drug Delivery System Production Capacity of Key Manufacturers in Global Market
8.3 Global Biodegradable Implantable Drug Delivery System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biodegradable Implantable Drug Delivery System Supply Chain Analysis
10.1 Biodegradable Implantable Drug Delivery System Industry Value Chain
10.2 Biodegradable Implantable Drug Delivery System Upstream Market
10.3 Biodegradable Implantable Drug Delivery System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biodegradable Implantable Drug Delivery System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
